New immunotherapy cures more children with lymphoma (Minard-Colin et al., 2020) A new combination treatment consisting of chemotherapy and the drug rituximab can cure a significant proportion of patients with B-cell non-Hodgkin lymphoma.
Checkpoint inhibitors in the treatment of pediatric solid tumors (Geoerger et al., 2020) In this study researchers determined whether the drug atezolizumab, a so-called checkpoint inhibitor, was active and safe to use in children with solid tumors, including lymphoma.